Stockreport

Erasca Reports Third Quarter 2025 Business Updates and Financial Results [Yahoo! Finance]

Erasca, Inc.  (ERAS) 
PDF Strengthened scientific leadership with promotion of Robert Shoemaker, Ph.D., to chief scientific officer Initial Phase 1 monotherapy data for ERAS-0015 and pan-KRAS [Read more]